Literature DB >> 1983918

The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands.

H J van Haastrecht1, J A van den Hoek, C Bardoux, A Leentvaar-Kuypers, R A Coutinho.   

Abstract

To determine if behavioral changes in intravenous drug users in Amsterdam have retarded the HIV (human immunodeficiency virus) epidemic in this group in recent years, we report that: HIV-antibody seroprevalence in annual samples of injectors has been constant over the years 1986-89; HIV-antibody incidence in a cohort of injectors appears to have decreased from 1986 to 1987 and stabilized after that until 1989; acute hepatitis B incidence in all drug users in Amsterdam declined rapidly between 1985-89. It is concluded that changes in drug use behavior so far appear to have resulted in a stabilization of the epidemic among injectors, at a level with a still disturbingly high incidence rate of 5-6 per 100 person-years.

Entities:  

Mesh:

Year:  1991        PMID: 1983918      PMCID: PMC1404932          DOI: 10.2105/ajph.81.1.59

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  6 in total

1.  Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS.

Authors:  J A van den Hoek; H J van Haastrecht; R A Coutinho
Journal:  Am J Public Health       Date:  1989-10       Impact factor: 9.308

2.  The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour.

Authors:  C Hartgers; E C Buning; G W van Santen; A D Verster; R A Coutinho
Journal:  AIDS       Date:  1989-09       Impact factor: 4.177

3.  Surrogate markers for HIV incidence among homosexual men.

Authors:  G J van Griensven; J A van den Hoek; A Leentvaar; R A Coutinho
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

4.  HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.

Authors:  D C Des Jarlais; S R Friedman; D M Novick; J L Sotheran; P Thomas; S R Yancovitz; D Mildvan; J Weber; M J Kreek; R Maslansky
Journal:  JAMA       Date:  1989-02-17       Impact factor: 56.272

5.  Preventing AIDS in drug addicts in Amsterdam.

Authors:  E C Buning; R A Coutinho; G H van Brussel; G W van Santen; A W van Zadelhoff
Journal:  Lancet       Date:  1986-06-21       Impact factor: 79.321

6.  Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam.

Authors:  J A van den Hoek; R A Coutinho; H J van Haastrecht; A W van Zadelhoff; J Goudsmit
Journal:  AIDS       Date:  1988-02       Impact factor: 4.177

  6 in total
  14 in total

1.  Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.

Authors:  C Hartgers; E J van Ameijden; J A van den Hoek; R A Coutinho
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

2.  Estimating the size of the HIV epidemic among injecting drug users in Amsterdam.

Authors:  H J van Haastrecht; P J Bindels; A A van den Hoek; R A Coutinho
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

3.  Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.

Authors:  Vana Sypsa; Mina Psichogiou; Dimitrios Paraskevis; Georgios Nikolopoulos; Chrissa Tsiara; Dimitra Paraskeva; Katerina Micha; Meni Malliori; Anastasia Pharris; Lucas Wiessing; Martin Donoghoe; Samuel Friedman; Don Des Jarlais; Georgios Daikos; Angelos Hatzakis
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

4.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Authors:  H Hagan; D C Jarlais; S R Friedman; D Purchase; M J Alter
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

5.  'Dropouts' or 'drop-ins'? Client retention and participation in New Haven's needle exchange program.

Authors:  K Khoshnood; E H Kaplan; R Heimer
Journal:  Public Health Rep       Date:  1995 Jul-Aug       Impact factor: 2.792

6.  A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.

Authors:  E J Van Ameijden; J A Van den Hoek; G H Mientjes; R A Coutinho
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

7.  HIV epidemiology and risk behavior promoting HIV transmission in Austrian prisons.

Authors:  J Pont; H Strutz; W Kahl; G Salzner
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

Review 8.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

9.  Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs.

Authors:  E J van Ameijden; A R van den Hoek; R A Coutinho
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

10.  Methadone treatment and risk of HIV infection in drug users without legal access to clean injection equipment.

Authors:  V Wietlisbach; G Meystre-Agustoni; J Martin
Journal:  Soz Praventivmed       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.